PubMed:20828385 / 0-98 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCoin-sentences

    {"project":"LitCoin-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":90},"obj":"Sentence"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    LitCoin-entities

    {"project":"LitCoin-entities","denotations":[{"id":"8028","span":{"begin":42,"end":54},"obj":"ChemicalEntity"},{"id":"8029","span":{"begin":69,"end":89},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"db_id","subj":"8028","obj":"MESH:C401859"},{"id":"A2","pred":"db_id","subj":"8029","obj":"MESH:D020522"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    LitCoin_Mondo

    {"project":"LitCoin_Mondo","denotations":[{"id":"T1","span":{"begin":69,"end":89},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":81,"end":89},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0018876"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0005062"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    LitCoin-GeneOrGeneProduct-v0

    {"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T1","span":{"begin":76,"end":80},"obj":"GeneOrGeneProduct"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    LitCoin-GeneOrGeneProduct-v2

    {"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":76,"end":80},"obj":"GeneOrGeneProduct"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    LitCoin-Disease-MeSH

    {"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T1","span":{"begin":69,"end":89},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"originalLabel","subj":"T1","obj":"D020522"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    LitCoin_Mondo_095

    {"project":"LitCoin_Mondo_095","denotations":[{"id":"T1","span":{"begin":69,"end":89},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0018876"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    LitCoin-MeSH-Disease-2

    {"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T1","span":{"begin":69,"end":89},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"D020522"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    LitCoin-MONDO_bioort2019

    {"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T1","span":{"begin":69,"end":89},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"D020522"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    LitCoin-Chemical-MeSH-CHEBI

    {"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T1","span":{"begin":42,"end":54},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"C401859"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    LitCoin-training-merged

    {"project":"LitCoin-training-merged","denotations":[{"id":"T1","span":{"begin":42,"end":54},"obj":"ChemicalEntity"},{"id":"T79309","span":{"begin":69,"end":89},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"C401859"},{"id":"A83127","pred":"#label","subj":"T79309","obj":"D020522"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":90},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":90},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    UBERON-AE

    {"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":69,"end":75},"obj":"http://purl.obolibrary.org/obo/UBERON_0006575"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    PubCasesHPO

    {"project":"PubCasesHPO","denotations":[{"id":"TI1","span":{"begin":81,"end":89},"obj":"HP:0002665"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    PubCasesORDO

    {"project":"PubCasesORDO","denotations":[{"id":"TI1","span":{"begin":69,"end":89},"obj":"ORDO:52416"}],"namespaces":[{"prefix":"ORDO","uri":"http://www.orpha.net/ORDO/Orphanet_"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}

    performance-test

    {"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":69,"end":75},"obj":"http://purl.obolibrary.org/obo/UBERON_0006575"},{"id":"PD-UBERON-AE-B_T2","span":{"begin":91,"end":97},"obj":"http://purl.obolibrary.org/obo/UBERON_0006575"}],"text":"Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.\nMantle "}